Skip to main content
Earnings Labs
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ·Healthcare·Biotechnology

$16.29

+0.40%

Mkt Cap $2.01B

Analyst Ratings

No recent rating data.

Price Target (9 analysts)

$15.50

Range $15.00$16.00

Implied Upside

-4.8%

Consensus $15.50 vs current $16.29